Skip to content

eNRMC Deadline Extended to 31 March 2027: Getting Your Home Ready

Two nurses in scrubs talking in a bright corridor
19 November 2026

The eNRMC aged care implementation timeframe for electronic-prescribing-conformant systems has been extended to 31 March 2027, from the previous 31 December 2026 target, according to the Department's residential news listing and its full extension notice. More precisely, the Department's 22 September 2026 transitional arrangement fact sheet says a home using a transitional eNRMC product may continue under that arrangement until 31 March 2027 and must upgrade its product version by that date. The operational difference after the deadline is about new orders and PBS prescriptions, not an instant invalidation of every existing chart.

Key Takeaways

  • The eNRMC transitional arrangement ends on 31 March 2027 for residential homes using transitional product versions.
  • From 1 April 2027, a transitional system must not generate new PBS prescriptions; if a home has not upgraded, a prescriber needs to issue a separate PBS prescription, on paper or electronically.
  • Prescriptions generated under the transitional arrangement before 1 April 2027 can remain valid for PBS claiming for their normal maximum validity period.
  • Providers should coordinate system transition, chart migration, training and testing with software suppliers, prescribers and pharmacies before the deadline.

What does the extension actually cover?

An electronic National Residential Medication Chart combines charting workflows in residential care with electronic prescribing capabilities when the product meets the relevant conformance requirements. The Department says sector and vendor feedback about the complexity of migrating residents' charts led to the extended timeframe. Its notice calls for continued system migration, user training, testing and medication chart re-creation. It is not a statement that all products currently used at a home already have the required conformant version installed.

The fact sheet gives the clearest operational boundary. From 1 April 2027, homes should use conformant electronic-prescribing eNRMC systems for new PBS medication orders. Transitional eNRMC systems must not generate new PBS prescriptions from that date, although the Department says they may continue to support medication administration. Where a home has not upgraded, prescribers need separate PBS prescriptions, either paper or electronic, for new orders. That limited paper-prescription pathway is not a general assurance that a paper chart is a long-term substitute for a conformant eNRMC implementation.

Existing PBS prescriptions made through a transitional system before 1 April 2027 may remain valid up to the maximum PBS validity period. Managers therefore need a clear distinction between orders made before and after the transition date, and a reliable handover between the chart, the prescriber and the pharmacy. This article does not prescribe a clinical process for particular medicines or residents.

Which system checks should managers make now?

First, ask the software supplier which installed version the home uses and whether the intended upgrade is an electronic-prescribing-conformant version. Get an implementation plan, migration method, testing window and support contacts in writing. The Department says it is updating its conformance status tracker and refers to the Australian Digital Health Agency's conformance register; check the current entry rather than treating a vendor assurance as the only evidence.

Second, plan chart re-creation and verification with the people who actually use the records. Record who migrates data, who checks completeness and how an unresolved discrepancy reaches the authorised clinician. A software installation alone does not show that a resident's current orders, discontinued orders, allergies and administration workflow have been reconciled. These are examples of project controls for a safe transition, not clinical instructions to alter a medication order.

Third, test ordinary days and exception paths before switching. Can authorised users access the new system at the points of care where they work? Does the pharmacy receive the information it needs? Can the prescriber see how a new order appears to nursing staff? When the network or product is unavailable, do local escalation and downtime procedures identify who is responsible for resolving the issue? Review these questions within the home's medication management policy, with clinical leadership approving any clinical workflow.

How do prescribers and pharmacies fit into readiness?

The Department's fact sheet expressly asks homes to coordinate with prescribers, pharmacies and staff. Arrange a joint transition timetable rather than sending a one-sided go-live notice. Agree which version will be used, when migrated charts are checked, how new prescriptions will be issued, and who receives a query if records do not match. A medication management system is more than the screen staff see: the prescribing, supply, administration and documentation interfaces need to work together.

Clinical leadership should decide the safe process for consent, escalation and authorised changes. Keep the organisation's consent for medication policy aligned with actual local practice, and use the clinical governance framework to assign oversight of incidents and unresolved risks. The linked policies are planning aids, not a replacement for advice from a prescriber or pharmacist. Staff can use Governa's medication management glossary for terminology before a training session.

What should training and fallback preparation include?

Give each role a test that reflects what it will actually do. Prescribers, pharmacists, registered nurses and other authorised staff have different tasks and permissions. Keep a dated record of attendance, observed competency and follow-up for staff who could not complete testing. A workforce training and competency policy can structure that record, but sign-off should be based on performance in the approved workflow, not attendance alone.

Document the fallback for a delayed upgrade before the deadline. The Department expressly allows a separate paper or electronic PBS prescription from the prescriber for new orders after 1 April if a home remains on a transitional product; it does not say the transitional product may keep creating new PBS prescriptions. Distinguish that prescribing exception from internal downtime procedures, and have the pharmacy and clinical governance leads agree how information will be reconciled when a system returns. Do not assume that 'paper charts are allowed' without checking the precise product, order and PBS context.

Keep a simple readiness record: supplier version and conformance status, migration date, partners consulted, tested workflows, staff competency, known defects and an owner for each open item. Escalate blockers while there is time to arrange a safe alternative. The extension was intended to reduce operational risk, not to remove the work of moving charts.

Related Resources

Common Questions About the eNRMC Transition

1. Was the eNRMC deadline really extended to 31 March 2027?

Yes. The Department's news notice and transitional arrangement fact sheet confirm the extension from 31 December 2026 to 31 March 2027 for the transition described there.

2. May a transitional eNRMC generate a new PBS prescription after March?

No. The Department says transitional systems must not generate new PBS prescriptions from 1 April 2027. A prescriber at a home that has not upgraded needs to issue a separate PBS prescription, on paper or electronically.

3. Do pre-April prescriptions become invalid overnight?

No. The Department says PBS prescriptions generated under the transitional arrangement before 1 April 2027 may remain valid for PBS claiming up to their normal maximum validity period.

4. Is purchasing software enough to be ready?

No. The Department also identifies migration, user training, testing and chart re-creation. Homes should coordinate the change with their prescribers and pharmacies.

5. Does the extension itself authorise a permanent paper-chart approach?

No. The Department identifies a separate paper or electronic PBS prescription route if an upgrade has not occurred, but that is not a blanket endorsement of any paper-chart model. Confirm the local clinical and prescribing requirements with the responsible professionals.

Test the Chart Before April

Ask the supplier for a dated conformant-version plan and bring prescribers, pharmacy and care staff into the same test. Record the remaining risks and the approved fallback for new PBS prescriptions if the upgrade slips. Use the extra time to prove the new workflow works for actual roles, not merely that the system opens. The first action is to identify the installed version and book the joint migration review.

AI POWERED

Stop chasing evidence. Start connecting it.

Governa aligns your policies, systems, and staff queries to the Strengthened Aged Care Quality Standards. Give your team instant, audit-ready answers — trusted by aged care providers across Australia.